Mediterra SA
AATHEX:MASTIHA1.18
EUR
-0.09
(-7.09%)
ISIN
GRS500003009
Return %
Stock
S&P 500
1Y
-27.16
14.20
3Y
-19.73
81.12
5Y
-27.16
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Semi-annual Revenue
FRC
•
in mil. unless spec.Semi-annual Earnings Per Share
FRC
•
in mil. unless spec.Semi-annual Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Ioannis Antoniou Mandalas
- Full Time Employees
- 84
- Sector
- Retail trade
- Industry
- Specialty stores
- Address
- Chios Greece
- IPO Date
- Feb 18, 2008
- Website
- mastihashop.com
- Similar Companies
- Business
- Mediterra SA is a Greece-based commercial and industrial enterprise engaged in the development, manufacturing, retail, and international distribution of products derived from Chios mastic (Pistacia lentiscus var. Chia) as well as traditional Mediterranean food, beverage, and wellness goods. Founded in 2002 and headquartered in Chios, Greece, the company operates as the commercial and marketing vehicle of the Chios Mastiha Growers Association, which serves as its primary shareholder. Mediterra SA organizes its commercial activities across four core operating divisions: Food and Confectionery, comprising ELMA brand natural mastic chewing gums, dragees, traditional loukoumi, spoon sweets, chocolates, baked biscuits, halva, pasta, culinary mastic crystals, and extra virgin olive oils; Beverages and Distillates, comprising protected designation of origin (PDO) Chios mastic liqueurs under the Enosis and Kentos labels, mastic-flavored spirits, ouzo, carbonated mastic table water, and herbal tea infusions; Personal Care and Cosmetics, comprising anti-aging facial creams, moisturizing body lotions, dermatological soaps, shampoos, conditioners, sunscreens, and dental hygiene products formulated with natural mastic essential oil; and Pharmaceuticals and Nutraceuticals, comprising natural gastrointestinal dietary supplements, therapeutic mastic capsules, digestive health formulations, and paramedical remedies marketed under the Art of Nature and mastihashop therapy brands. The company operates a dedicated retail store network under the mastihashop brand across domestic and international locations, airport duty-free retail points, shop-in-shop corners, and direct-to-consumer e-commerce channels, exporting to markets across Europe, North America, the Middle East, and Asia. In recent developments, Mediterra SA transferred the trading of its shares to the Regulated Main Market of the Athens Exchange (ATHEX: MASTIHA) from the Alternative Market (EN.A.), strengthening its institutional visibility and capital structure. The company has also expanded operations at the Chios Mastiha Research Center in Kallimasia to accelerate clinical research and patent development for mastic applications in gastroenterology, established expanded distribution alliances with pharmaceutical partners across international markets, and modernized its mastihashop omnichannel retail and digital commerce platforms.